• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: LEICA BIOSYSTEMS MELBOURNE PTY. LTD. PELORIS RAPID TISSUE PROCESSOR; AUTOMATED TISSUE PROCESSOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

LEICA BIOSYSTEMS MELBOURNE PTY. LTD. PELORIS RAPID TISSUE PROCESSOR; AUTOMATED TISSUE PROCESSOR Back to Search Results
Model Number PELORIS
Device Problems Leak/Splash (1354); Mechanical Problem (1384)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 05/02/2017
Event Type  malfunction  
Manufacturer Narrative
The sub-optimal tissue processing reported by the complainant is derived from the "2 hour biopsy" protocol started in retort b at 17:49 pm on (b)(6) 2017, which completed successfully at 03:00 am on (b)(6) 2017.Investigation of this complaint found that the instrument functioned as designed during execution of the "9.5 hour large tissue" protocol started in retort a at 18:24 pm and the "2 hour biopsy" protocol started in retort b at 18:25 pm on (b)(6) 2017, as a consequence of a leaking retort a wax valve.The user actions in response to the "1337" error code generated by the sudden, unexpected drop in the retort wax line temperature caused by the leaking retort a wax valve were in accordance with the information displayed on the instrument monitor, which is not to use the instrument and to contact service.The instrument functioned within specification during execution of the "2 hour biopsy" protocol started in retort b at 17:49 pm on (b)(6) 2017, from which sub-optimal tissue processing was reported by the complainant on (b)(6) 2017.The root cause of the sub-optimal tissue processing reported by the complainant is the use of formalin contaminated wax for the wax infiltration step of the protocol.The root cause of the wax contamination with formalin was failure of the fse to complete on (b)(6) 2017 all steps of the manufacturer specified regimen for troubleshooting the "1337" error code, which had been generated at 18:26 pm on (b)(6) 2017 for retort a and indicated a leaking retort wax valve.Section 6.6 technical service bulletin (tsb) b26.5066.680 peloris error 1337 troubleshooting stipulates that the least concentrated wax is drained through a retort and that both retort wax lines are subsequently cleaned prior to returning to clinical use.In this instance, they do not show any evidence that the wax in any of the four (4) wax chambers had been replaced.As a consequence, any reagent (including formalin) contamination remaining in the retort a wax line would have been drawn into the retort during execution of the wax step in subsequent processing runs; which would in turn result in water being re-introduced into tissue samples during wax infiltration and the sub-optimal tissue processing reported.
 
Event Description
Leica biosystems received a complaint that "water in paraffin" following completion of the routine biopsy 2 hour protocol.The complainant advised that 70 biopsies may have been affected.On 18 may 2017, leica biosystems received information that all tissue samples exhibiting sub-optimal tissue processing were diagnosable.On 01 may 2017, a leica field service engineer (fse), attended the laboratory in response to a complaint (service order: (b)(4)) regarding display of error code "1337", which indicates a leaking retort wax valve, and the associated information displayed not to use the instrument and to contact service.The fse documented that performance tests were conducted; the wax valve for retort a was re-built and technical service bulletin (tsb) b26.5066.680 peloris error 1337 troubleshooting has been applied.The fse also documented that the complainant confirmed that no tissue sample(s) had been adversely affected as a consequence of the circumstances involved.On 05 may 2017, the fse returned to the laboratory in response to this compliant.The fse documented that the retort wax valve on retort b was replaced and technical service bulletin (tsb) b26.5066.680 peloris error 1337 troubleshooting has been applied.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PELORIS RAPID TISSUE PROCESSOR
Type of Device
AUTOMATED TISSUE PROCESSOR
Manufacturer (Section D)
LEICA BIOSYSTEMS MELBOURNE PTY. LTD.
495 blackburn road
mount waverley, 3149
AS  3149
Manufacturer (Section G)
LEICA BIOSYSTEMS MELBOURNE PTY. LTD.
495 blackburn road
mount waverley, 3149
AS   3149
Manufacturer Contact
adrienne hardisty
495 blackburn road
mount waverley, 3149
AS   3149
92117535
MDR Report Key6603942
MDR Text Key76408866
Report Number8020030-2017-00031
Device Sequence Number1
Product Code IEO
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 05/02/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/01/2017
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Other
Device Model NumberPELORIS
Device Catalogue Number26.0005
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Date Manufacturer Received05/02/2017
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured08/25/2009
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
-
-